TECHNOLOGY LICENSING OPPORTUNITY: SmartBind pH Switch
| Agency: | ENERGY, DEPARTMENT OF |
|---|---|
| State: | New Mexico |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Nov 13, 2025 |
| Due Date: | Dec 5, 2025 |
| Solicitation No: | S-133461 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Nov 13, 2025 03:06 pm MST
- Original Response Date: Dec 05, 2025 05:00 pm MST
- Inactive Policy: Manual
- Original Inactive Date: Dec 05, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
Los Alamos , NM 87545USA
This innovation from scientists at Los Alamos National Laboratory is a significant improvement on a gold standard protein purification method that gently captures and releases antibodies using mild pH changes, making antibody purification safer, more efficient, and less damaging.
The Challenge:
Purifying antibodies — vital tools in medicine and research — typically relies on a protein called Protein G that latches onto them. However, getting the antibodies back off this molecular “magnet” requires very acidic conditions, which can damage both the antibodies and Protein G itself. This harsh process risks ruining expensive materials and reducing the effectiveness of critical therapies and tests.
Problems Solved:
Researchers engineered a pH-switchable version of Protein G that uses gentle changes in acidity (pH) to control when it releases antibodies, it now binds antibodies at a mildly acidic pH and releases at a mildly basic pH — eliminating the need for harsh chemicals. This innovation protects sensitive proteins, improves efficiency, lowers costs, and opens the door for safer, greener, and more effective antibody purification in both labs and industry.
Key Advantages:
- Gentle elution conditions: Antibodies are released at a mild pH (~8.2) instead of harsh acidic conditions (~2.7), reducing damage to both the antibodies and the protein itself.
- Improved antibody stability and yield: Preserving antibody structure increases reliability and effectiveness, which is especially critical for therapeutic and diagnostic use.
- Switchable binding mechanism: pH-sensitive histidine residues allow for a controlled "on/off" switch based on pH, improving process control and reproducibility.
- Cost-effective and scalable: Reduces loss of expensive antibodies and minimizes the need for post-purification repair or replacement, saving money in industrial applications.
Market Applications:
- Biopharmaceuticals
- Life Sciences Research
- Bioprocessing and Manufacturing Tools
- Veterinary and Agricultural Biotech
Development Status: TRL 4
US Provisional / Patent No. 10,954,275
LA-UR-25-29451
LANL Tech Partnerships: Unlock the Innovative Potential
Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products.
LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov.
Note: This is not a call for external services for the development of this technology.
https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology
https://www.lanl.gov/engage/collaboration/feynman-center/tech-and-capability-search
- 505 King Ave
- Columbus , OH 43201
- USA
- Marc Witkowski
- licensing@lanl.gov
- Lindsay Augustyn
- licensing@lanl.gov
- Nov 13, 2025 03:06 pm MSTSpecial Notice (Original)
See Also
Economic Modeling DBA Lightcast Sole Source Pre-Award $98,508 Economic Modeling DBA Lightcast Sole
New Mexico State University
Due by 9/16/2026
RFP TC FY26-27-005 Fully Insured Vision TC FY26-27-005 / 08/18/2026 TORRANCE COUNTY REQUEST
Torrance County
Due by 9/17/2026
Follow TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform Active Contract Opportunity Notice ID S-195396
ENERGY, DEPARTMENT OF
Due by 12/03/2026
Follow All in one visual acuity system Active Contract Opportunity Notice ID IHS1511834
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 4/29/2029